Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Glutathione solution will be infused
We recently solved the crystal structure of the GLP-1 receptor extracellular domain in complex with the competitive antagonist exendin-4(9-39)
Moreover, our results demonstrate that specific dual action therapies (e.g., insulin glargine and lixisenatide, insulin degludec and liraglutide) exhibit efficacy comparable to metformin
For example, a recent market report forecasts that the global obesity drug market (fueled by GLP-1s and similar incretin therapies) could exceed $50 billion by 2030
US$ 22.46
US$ 29.50
US$ 20.59
US$ 26.89
